Boston Scientific shares slid -1.9% this afternoon. Here's what you need to know about the large-capMedical instruments & supplies company:
-
Boston Scientific has logged a 19.9% 52 week change, compared to -3.3% for the S&P 500
-
BSX has an average analyst rating of buy and is -4.22% away from its mean target price of $53.89 per share
-
Its trailing earnings per share (EPS) is $0.45, which brings its trailing Price to Earnings (P/E) ratio to 114.7. The Health Care sector's average P/E ratio is 24.45
-
The company's forward earnings per share (EPS) is $2.16 and its forward P/E ratio is 23.9
-
The company has a Price to Book (P/B) ratio of 4.2 in contrast to the Health Care sector's average P/B ratio is 4.16
-
The current ratio is currently 1.5, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
BSX has reported YOY quarterly earnings growth of 56.7% and gross profit margins of 0.7%
-
The company's free cash flow for the last fiscal year was $914,000,000.00 and the average free cash flow growth rate is -9.7%
-
Boston Scientific's revenues have an average growth rate of 4.3% with operating expenses growing at 3.4%. The company's current operating margins stand at 16.0%